Absence of factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in North India

N Gupta1, F Khan, M Tripathi

  • 1Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rai Bareilly Road, Lucknow - 226 014, India.

Insights

Factor V Leiden mutation and FII G20210A polymorphism were absent in North Indian populations, indicating they are not independent risk factors for coronary artery disease (CAD) or myocardial infarction in this group.

Area of Science:

  • Cardiovascular Genetics
  • Thrombosis Research

Background:

  • Coronary artery diseases (CADs) result from complex interactions between genetic and environmental factors.
  • Factor V Leiden mutation (FVL) and FII G20210A polymorphism are linked to venous thrombosis but their role in CAD is uncertain.

Purpose of the Study:

  • To investigate the association of FVL and FII G20210A polymorphisms with CAD in a North Indian population.
  • To determine if these genetic factors are independent risk factors for myocardial infarction.

Main Methods:

  • A case-control study involving 200 patients with angiographically proven CAD and 200 age- and sex-matched controls from North India.
  • Genotyping for Factor V Leiden mutation and FII G20210A polymorphism was performed.

Main Results:

  • Both Factor V Leiden mutation and FII G20210A polymorphism were found to be completely absent in the studied North Indian population.
  • Consequently, these genetic variants could not be established as independent risk factors or predictors for CAD in this cohort.

Conclusions:

  • The studied polymorphisms (FVL and FII G20210A) are not independent risk factors for CAD or myocardial infarction in the North Indian population.
  • Further research is recommended to validate these findings in diverse Indian populations, given reported variations in FVL incidence elsewhere.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...